CATALYTAC

Serial Number 98840485
641

Registration Progress

Application Filed
Nov 6, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action Mailed
Due: Aug 24, 2025 34 days

Trademark Image

CATALYTAC

Basic Information

Serial Number
98840485
Filing Date
November 6, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
641
Status Date
May 24, 2025
Application
Pending
Classes
005 042 044

Rights Holder

Lycia Therapeutics, Inc.

03
Address
400 East Jamie Ct., Suite 200
South San Francisco, CA 94080

Ownership History

Lycia Therapeutics, Inc.

Original Applicant
03
South San Francisco, CA

Legal Representation

Attorney
Connie L. Ellerbach

USPTO Deadlines

Next Deadline
34 days remaining
Non-Final Action Mailed
Due Date
August 24, 2025
Extension Available
Until November 24, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

6 events
Date Code Type Description Documents
May 24, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 24, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 24, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 5, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 26, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 6, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations comprising small molecules and antibodies for degrading disease-causing cellular proteins for treatment of cancer, autoimmune diseases, immunologic-based diseases, neurological diseases, and other human diseases; Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases, neurological diseases, and other human diseases; Biological preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases, neurological diseases, and other human diseases; Gene therapy products, namely, biological preparations for the treatment of cancer, autoimmune diseases, immunologic-based diseases, neurological diseases, and other human diseases; Pharmaceutical preparations for use in gene therapy; Biological preparations for use in gene therapy; Viruses for therapeutic purposes, namely, for gene therapy and antivirals
Class 042
Research and development services in the field of pharmaceuticals; drug discovery services
Class 044
Providing medical information; Providing medical information via a website; Medical services; Medical diagnostic testing, medical clinics, medical screenings, medical examinations and medical treatment services; Provision of pharmaceutical information; Pharmaceutical services, consultations and advice

Classification

International Classes
005 042 044